Skip to main content

HighTower Advisors, LLC

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1462245 CHICAGO, IL

Position in ESPR

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$0
+$0 QoQ
Shares Held
13,021
-90.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Derivatives in ESPR

reported options exposure · as of Dec 31, 2024
CallValue
$0
CallShares
19,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

HighTower Advisors, LLC holds $47,963,007 across 28 Drug Manufacturers - Specialty & Generic names. ESPR ranks #28 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 13,021
2026-03-31 141,152
2025-12-31 113,899
2025-09-30 120,011
2025-06-30 118,339
2025-03-31 124,886
2024-12-31 19,500
2024-12-31 104,261
2024-09-30 17,000
2024-09-30 105,571
2024-06-30 236,785
2024-06-30 13,000
2024-03-31 10,200
2024-03-31 187,166
2023-12-31 49,569
2023-12-31 1,000
2023-09-30 24,358
2023-06-30 23,593
2020-09-30 32,753
2020-06-30 1,000
2020-06-30 20,568
2020-03-31 3,400
2020-03-31 20,593